BIOA vs BCAX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

BIOA

45.2
AI Score
VS
BCAX Wins

BCAX

50.9
AI Score

Investment Advisor Scores

BIOA

45score
Recommendation
HOLD

BCAX

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BIOA BCAX Winner
Net Income -80.61M -111.65M BIOA
Operating Income -92.78M -120.19M BIOA
ROE -29.6% -23.8% BCAX
ROA -27.3% -21.8% BCAX
Total Assets 294.89M 512.24M BCAX
Cash 188.89M 96.60M BIOA
Current Ratio 14.24 11.59 BIOA
Free Cash Flow -82.35M -81.83M BCAX

Relative Price Performance (Last 90 Days)

BIOA 1M: -19.0% · 3M: -48.4% BCAX 1M: -7.4% · 3M: +7.2%

Current Technical Phase

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -21.1%), weak momentum, RSI 30

RSI (14): 29.5 · Price: $8.49

BCAX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 39.5 · Price: $22.81

Fundamentals Snapshot

Metric BIOA BCAX
Market Cap
Forward P/E -3.5 -6.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin -7.5%
Operating Margin -12.0% 0.0%
EPS -2.25 -3.00
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BCAX is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.